Pfizer asks the FDA to authorize its vaccine for children between 5 and 11 years old
The pharmaceutical companies Pfizer and BioNTech announced ten days ago that the results of the latest clinical tests have generated a "robust" antibody response and that the vaccine is safe.
The pharmaceutical companies Pfizer and BioNtech formally requested this Thursday from the Food and Drug Administration ( FDA ) of the United States the authorization for the emergency use of its vaccine against covid-19 in children from 5 to 11 years old.
On its Twitter account, Pfizer confirms that it has made this request for authorization.
So far the FDA only authorizes the use of this vaccine from the age of twelve.
Last week, the US surgeon general (the main person in charge of public health in the country), Vivek Murthy, assured that vaccines for children between five and eleven years old "are already on the horizon."
The pharmaceutical companies Pfizer and BioNTech announced ten days ago that the results of the latest clinical tests have generated a "robust" antibody response and that the vaccine is safe, which brings the possibility of an infant serum available by the end of October or the beginning of October. November.
After submitting this request, now the regulatory bodies - the FDA and the Centers for Disease Control (CDC) - will have to review the request before giving it the green light.
SOURCE: EFE
On its Twitter account, Pfizer confirms that it has made this request for authorization.
So far the FDA only authorizes the use of this vaccine from the age of twelve.
Last week, the US surgeon general (the main person in charge of public health in the country), Vivek Murthy, assured that vaccines for children between five and eleven years old "are already on the horizon."
The pharmaceutical companies Pfizer and BioNTech announced ten days ago that the results of the latest clinical tests have generated a "robust" antibody response and that the vaccine is safe, which brings the possibility of an infant serum available by the end of October or the beginning of October. November.
After submitting this request, now the regulatory bodies - the FDA and the Centers for Disease Control (CDC) - will have to review the request before giving it the green light.
SOURCE: EFE
